Please login to the form below

Not currently logged in

ICR appoints Kristian Helin as its new chief executive

Helin will join ICR in September from the Memorial Sloan Kettering Cancer Center in the US

The Institute of Cancer Research, London has appointed Kristian Helin (pictured above) as its new chief executive, with the ‘world-leading’ cancer researcher set to take on the position in September.

Helin was founding director of a scientific institute in his native Denmark, and has previously led research centres in Italy and the US, and also founded biotech company EpiTherapeutics.

His previous experience includes spending 15 years as director of BRIC, a biotech and innovation institute at the University of Copenhagen. He was also a unit and division director at the European Institute of Oncology in Milan.

Helin will join the ICR from Memorial Sloan Kettering Cancer Center in the US, where he currently serves as chair of the cell biology programme and director of the Center for Epigenetics Research.

He takes over as chief executive from Paul Workman, who announced his intention to step down from the role in December 2019.

Workman will continue in his role as chief executive until the end of August to ensure a ‘smooth’ leadership transition.

“The ICR is known around the world both for fundamental scientific discoveries about cancer, and for working closely with The Royal Marsden and other partners to take those advances to patients through pioneering translational and clinical research,” said Helin.

“I am looking forward to working closely with colleagues in the NHS, academia, industry and at research funders to build on the ICR’s achievements so far, and ensure it continues to deliver world-class research that is closely focused on improving the lives of patients,” he added.

28th April 2021

From: Research



COVID-19 Updates and Daily News

Featured jobs


Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

The power of communication: Engaging diverse groups in healthcare
Humans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to a group, a cohort or an imagined section of society - especially...
Building the hospital of the future
Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....
Why people join a clinical trial
To understand why people decide to take part in clinical trials, you first need to understand how people make decisions....